Design, Synthesis, Spectral Charecterization of Some New Fully Unsaturated 2-Substituted-4, 6 Dichloro  Symmetric Triazine- Based Chalcone Hybrids

G.V.Pavan Kumar; B. Pooja; G. Harika; Y. Anil Kumar

Authors

G.V.Pavan Kumar
B. Pooja
G. Harika
Y. Anil Kumar

Keywords:

fully unsaturated, 1, 3, 5-triazine-chalcone hybrids, spectral characterization

Abstract

Triazines and chalcones are interesting class of heterocyclic compounds with a prominent structural core system present in numerous pharmacologically active compounds. It is proved from the literature that the compounds containing 1,3,5-triazine moiety or chalcone bridge often shows significant biological activity profiles. Based on these observations, it was considered worthwhile to synthesize and characterize some new 1,3,5-triazine-chalcone hybrid molecules in the present investigation. As a part of our research program aimed at search for new hybrid pharmacophores as potential cytotoxic agents, we are interested to have α,β-unsaturated ketone linker to the 1,3,5-triazine basic nucleus to give a series of 1,3,5-triazinechalcone hybrid molecules. Therefore, in the present study an attempt has been made to synthesize and characterize various analogs of fully unsaturated 2-substituted-4,6 dichloro-1,3,5 triazine based chalcone hybrids.

Downloads

How to Cite

Design, Synthesis, Spectral Charecterization of Some New Fully Unsaturated 2-Substituted-4, 6 Dichloro Symmetric Triazine- Based Chalcone Hybrids. (2016). Global Journal of Medical Research, 16(12), 17-29. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

Ohsawa A., Arai H., Ohnishi H., Igeta H. (1981) Ohsawa A.; Arai H.; Ohnishi H.; Igeta H. J. Chem. Soc., Chem. 1981, 1174.

B. Grzegorz (2006) 62, 9507.

Kim H., Dietrich W., Hansch C., Dolnick J., Bertino R. (1980) Kim K. H.; Dietrich S. W.; Hansch C.; Dolnick B. J.; Bertino J. R. J. Med. 23, 1248.

Blaney M., Hansch C., Silipo C., Vittoria A.

Foster B.J., Harding B.J., Leyland-Jones B., Hoth D. (1986) Foster B.J.; Harding B.J. Leyland-Jones B.; Hoth D. Cancer Treat. 38, 197.

C. Labrid, G. Regnier, M. Laubie, Eur

Ono M., Kawahara N., Goto D., Wakabayashi Y., Ushiro S., Yoshida S., Izumi H., Kuwano M., Sato Y. (1996) Ono M.; Kawahara N.; Goto D.; Wakabayashi Y.; Ushiro S.; Yoshida S.; Izumi H.; Kuwano M.; Sato Y. 56(7), 1512.

Baker R., Ashton T. (1973) Baker B. R.; Ashton W. T. J. Med. 16, 209.

Sirawaraporn W., Sathitkul T., Sirawaraporn R., Y. Yuthavong, Santi V. Sirawaraporn W.; Sathitkul T.; Sirawaraporn R.; Yuthavong, Y.; Santi D.

R. Patel, P. Kumari, D. Rajani, K. Chikhalia (2011) Patel, R. V.; Kumari, P.; Rajani, D. P.; Chikhalia, K. H. Eur. J. of Med. 46, 4354.

Thurston T., Schaefer C., Dudley R, Holm- D., Illuminati G. (1951) Thurston J. T.; Schaefer F. C.; Dudley J. R; Holm- Hansen D. Illuminati G. J. Am. Chem. 73, 2992.

R. Patel (2011) V.; Kumari, P.; Rajani, D P.; Chikhalia, K H Eur J Med Chem. 46, 4354-4365.

N. Somayajulu, L. Divakara, V. Kasapu, A. Rao, B. Bugata, S. Yenupuri, J. Eur, Chem Somayajulu, N.; Divakara, L.; Kasapu, V.

Bugata, B.; Krishna, K.; Satya, V. V.; Avupati (2013) R.; Gavalapu, V.; Somayajulu, N.; Divakara, L.; Barla, S Eur J Chem. 4(4), 396-401.

J. Raval, Eur (2011) P Eur J Chem. 2(3), 388-393.